This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Regenerative Medicine Market

Market Insights on Regenerative Medicine covering sales outlook, demand forecast & up-to-date key trends

Regenerative Medicine Market by Technology (Stem Cell Therapy, Biomaterial, Tissue Engineering), Application (Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Bones, Autogenic Bones, Others) & Region - Forecast to 2016-2026

Introduction

The global regenerative medicine (bone and joint) market is estimated at US$ 4,254.0 Mn in 2015 and is expected to grow at a double digit CAGR during the forecast period of 2015 - 2019.

Customize this Report

Let us know your requirement to get
100% FREE customization

Tissue Engineering Segment to Fuel the Regenerative Medicine Market Growth

The Global Regenerative Medicine Market is expected to observe the highest growth coming from the Tissue Engineering segment. By technology type, biomaterial segment currently holds the largest market share of global regenerative medicine market. However, Tissue Engineering segment is anticipated to be the fastest growing segment over the forecast period. In terms of value, the tissue engineering segment market is expected to expand at an outstanding CAGR of 17.5% over the forecast period of 2015-2019, to reach a market value of about US$ 1,070 Mn by 2019. Currently, tissue engineering segment accounts for almost 13.2% of the total share of the global regenerative medicine market, which is expected to increase potentially by 2019 end. The tissue engineering segment observed a year-on-year growth rate of about 22% during the year 2015.

Tissue Engineering Technology in Regenerative Medicine - Market Dynamics

Drivers

Tissue engineering is a new field in bone and joint reconstruction and considered a promising segment in the global regenerative medicine (bone and joint) market due to technological innovations (nanotechnology based tissue engineering). Tissue engineering products comprise minimally manipulated components such as biomaterials and cells. Researchers prefer next generation tissue engineered biomaterial based technologies for delivery of drugs, cells and genes.

Hence, products manufactured by the technology comprise multiple components such as cells, scaffold and growth factors. Therefore, next generation tissue engineered products would revolutionize the scope of the regenerative medicine market for bone and joint applications. Thus, technological innovations in biomaterials, stem cell therapy and tissue engineering would drive the global regenerative medicine (bone and joint) market.

Moreover, extensive government support in tissue engineering for the development of innovative treatment would drive the global regenerative medicine (bone and joint) market. For instance, in the U.K., most tissue engineering regenerative medicine projects are reviewed and supported by four research councils: Engineering and Physical Sciences Research Council (EPSRC), Medical Research Council (MRC), The Biotechnology and Biological Sciences Research Council (BBSRC) and Economic and Social Research Council (ESRC).

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Restrains

However, strict regulatory compliance for tissue engineered products would hamper demand for tissue engineered regenerative medicine products. In addition, ethical hurdles (use of human tissue for commercial production) with context to tissue engineered products would restrict the demand for regenerative medicine tissue engineering products.

Regenerative Medicine Market Download Report Brochure

Tissue Engineering Technology in Regenerative Medicine – Market Performance

The market size for tissue engineering technology in regenerative medicine market stood at US$ 200 Mn in the year 2011. The technology observed a good penetration rate in the following year and the market reached US$ 450 Mn in the year 2014, demonstrating a CAGR of close to 30%. Overall, the market is anticipated to grow at an impressive CAGR of close to 23% over the 8 years period, from 2011 till 2019.

Key Players in Tissue Engineering Technology Market

Major players in the tissue engineering segment include Arthrex, Inc. (Osteochondral Autograft Transfer System), DePuy Synthes, Inc. (COR and COR2) and Smith & Nephew plc. (Mosaicplasty System).

In the year 2015, Biomaterial technology type held the largest market share of over 60% of the global regenerative medicine market. The segment is estimated to remain the largest market share holder throughout the forecast period. Stem Cell Therapy technology segment is expected to be the second largest market share holder. However, the segment is anticipated to grow at the lowest CAGR in comparison with other technology types for regenerative medicine market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Key Segments Covered

The global regenerative medicine (bone and joint) market is segmented as follows:

Regenerative Medicine (Bone and Joint) Market, by Technology

  • Stem Cell Therapy
  • Biomaterial
  • Tissue Engineering

Regenerative Medicine (Bone and Joint) Market, by Application

  • Bone Graft Substitutes
  • Osteoarticular Diseases
  • Allogeneic Bones
  • Autogenic Bones
  • Others

Regenerative Medicine (Bone and Joint) Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Frequently Asked Questions

Demand for regenerative medicine is likely to grow at a CAGR of 23% through 2032.

Sales of regenerative medicine is likely to exceed a valuation of US$ 107 Bn by 2032.

Adoption of regenerative medicine is likely to reach a valuation of US$ 13.5 Bn in 2022.

North America is the key regenerative medicine market contributor.

Table of Content

1. Introduction 

1.1 Report Description 

1.2 Market Segmentation 

1.3 Research Methodology 

1.3.1 Assumptions 

1.4 List of Abbreviations 

2. Executive Summary 

2.1 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2015 & 2019)

2.2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2015 (US$ Mn) 

2.3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2015 and 2019 (Value %) 

3. Market Overview 

3.1 Overview 

3.2 Market Drivers 

3.3 Restraints 

3.4 Opportunities 

3.5 Porter’s Five Force Analysis: Global Regenerative Medicine (Bone and Joint) Market 

3.5.1 Bargaining power of suppliers 

3.5.2 Bargaining power of buyers 

3.5.3 Threat of new entrants

3.5.4 Threat of substitutes

3.5.5 Competitive rivalry 

3.6 Competitive Landscape 

3.6.1 Market Share Analysis by Key Players, 2012 (Value %) 

3.7 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography 

4. Regenerative Medicine (Bone and Joint) Market, by Technology 

4.1 Introduction 

4.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (US$ Mn) 

4.2 Stem Cell Therapy 

4.2.1 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (US$ Mn) 

4.3 Biomaterials 

4.3.1 Global Biomaterials Market Revenue, 2011 – 2019 (US$ Mn) 

4.4 Tissue Engineering

4.4.1 Global Tissue Engineering Market Revenue, 2011 – 2019 (US$ Mn) 

5. Regenerative Medicine (Bone and Joint) Market, by Applications 

5.1 Overview 

5.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (US$ Mn) 

5.2 Bone Graft Substitutes 

5.2.1 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (US$ Mn) 

5.3 Osteoarticular Diseases 

5.3.1 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (US$ Mn) 

5.4 Allogeneic Bones 

5.4.1 Global Allogeneic Bones Application Market Revenue, 2011 – 2019 (US$ Mn) 

5.5 Autogenic Bones 

5.5.1 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (US$ Mn) 

5.6 Others 

5.6.1 Global Others Application Market Revenue, 2011 – 2019 (US$ Mn) 

6. Regenerative Medicine (Bone and Joint) Market, by Geography 

6.1 Overview 

6.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (US$ Mn) 

6.2 North America 

6.2.1 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn) 

6.3 Europe 

6.3.1 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn) 

6.4 Asia-Pacific 

6.4.1 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn) 

6.5 Rest of the World (RoW) 

6.5.1 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn) 

7. Recommendations 

7.1 Market Strategy for Success 

7.1.1 Rigorous research and development initiatives for innovative products 

7.1.2 Investing in emerging economies 

7.2 Barriers and Future Assumptions 

7.2.1 Ethical issues pertaining to stem cell therapy hampering market growth 

8. Company Profiles 

8.1 Anika Therapeutics, Inc. 

8.1.1 Company Overview 

8.1.2 Financial Overview 

8.1.3 Product Portfolio 

8.1.4 Business Strategies 

8.1.4.1 Distribution agreements for business expansion 

8.1.5 Recent Developments 

8.2 Arthrex, Inc. 

8.2.1 Company Overview 

8.2.2 Financial Overview 

8.2.3 Product Portfolio 

8.2.4 Business Strategies 

8.2.4.1 Mergers and acquisitions for business expansion 

8.2.4.2 Distribution agreement for market penetration 

8.2.5 Recent Developments 

8.3 Baxter International, Inc. 

8.3.1 Company Overview 

8.3.2 Financial Overview 

8.3.3 Product Portfolio 

8.3.4 Business Strategies 

8.3.4.1 Acquisition for business expansion 

8.3.4.2 Public-private partnership for market penetration 

8.3.4.3 New product development 

8.3.5 Recent Developments 

8.4 CONMED Corporation 

8.4.1 Company Overview 

8.4.2 Financial Overview 

8.4.3 Product Portfolio 

8.4.4 Business Strategies 

8.4.4.1 Merger and acquisition for business expansion 

8.4.5 Recent Developments 

8.5 DePuy Synthes, Inc. 

8.5.1 Company Overview 

8.5.2 Financial Overview 

8.5.3 Product Portfolio 

8.5.4 Business Strategies 

8.5.4.1 Extensive research and development activities 

8.5.4.2 Relationship with healthcare professionals 

8.5.5 Recent Developments 

8.6 Medtronic, Inc. 

8.6.1 Company Overview 

8.6.2 Financial Overview 

8.6.3 Product Portfolio 

8.6.4 Business Strategies 

8.6.4.1 Strategic partnership and acquisition 

8.6.5 Recent Developments 

8.7 Smith & Nephew plc 

8.7.1 Company Overview 

8.7.2 Financial Overview 

8.7.3 Product Portfolio 

8.7.4 Business Strategies 

8.7.4.1 Mergers and acquisitions for business expansion 

8.7.4.2 Distribution strategies for market penetration 

8.7.5 Recent Developments 

8.8 Stryker Corporation 

8.8.1 Company Overview 

8.8.2 Financial Overview 

8.8.3 Product Portfolio 

8.8.4 Business Strategies 

8.8.4.1 Focus on R&D activities 

8.8.4.2 Acquisitions for market penetration 

8.8.5 Recent Developments 

8.9 Zimmer Holdings, Inc. 

8.9.1 Business Overview 

8.9.2 Financial Overview 

8.9.3 Product Portfolio 

8.9.4 Business Strategies 

8.9.4.1 Mergers and acquisitions for business expansion 

8.9.5 Recent Developments 

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

TABLE 1 List of Abbreviations

TABLE 2 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2015 & 2019)

TABLE 3 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (US$ Mn) 

TABLE 4 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (US$ Mn) 

TABLE 5 Comparative Analysis: Various Bone Graft Substitutes

TABLE 6 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (US$ Mn) 

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

FIG. 1 Regenerative Medicine (Bone and Joint): Market Segmentation

FIG. 2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2015 (US$ Mn)

FIG. 3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2015 & 2019 (Value %)

FIG. 4 Porter’s Five Forces Analysis: Global Regenerative Medicine (Bone and Joint) Market

FIG. 5 Market Share Analysis: Regenerative Medicine (Bone and Joint) Market, 2012 (Value %)

FIG. 6 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2015 Value (%)

FIG. 7 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 8 Global Biomaterials Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 9 Global Tissue Engineering Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 10 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 11 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 12 Global Allogeneic Bones Application Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 13 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 14 Global Others Application Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 15 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn) 

FIG. 16 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 17 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn) 

FIG. 18 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (US$ Mn)

FIG. 19 Anika Therapeutics, Inc.: Annual Revenue, 2011 – 2013 (US$ Mn)

FIG. 20 Baxter International, Inc.: Annual Revenue, 2011 – 2013 (US$ Mn)

FIG. 21 Conmed Corporation: Annual Revenue, 2011 – 2013 (US$ Mn)

FIG. 22 Johnson & Johnson, Orthopedic Franchise**, Annual Revenue: 2011 – 2013 (US$ Mn)

FIG. 23 Medtronic, Inc.: Annual Revenue, 2011 – 2013 (US$ Mn)

FIG. 24 Smith & Nephew PLC: Annual Revenue, 2011 – 2013 (US$ Mn)

FIG. 25 Stryker Corporation: Annual Revenue, 2011 – 2013 (US$ Mn)

FIG. 26 Zimmer Holdings. Inc,: Annual Revenue, 2011 – 2013 (US$ Mn)

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Regenerative Medicine Market